Pages that link to "Item:Q5424156"

The following pages link to Ethical considerations concerning treatment allocation in drug development trials (Q5424156):

Displaying 16 items.

• The finite sample performance of the two-stage analysis of a two-period crossover trial (Q310650) (← links)
• Estimation of the proportion ratio under a simple crossover trial (Q425644) (← links)
• Robustness and monotonicity properties of generalized correlation coefficients (Q607215) (← links)
• Notes on estimation in Poisson frequency data under an incomplete block crossover design (Q670120) (← links)
• Notes on testing equality in binary data under a three period crossover design (Q1623697) (← links)
• Test and estimation in binary data analysis under an incomplete block crossover design (Q1623734) (← links)
• Maximin efficiencies under treatment-dependent costs and outcome variances for parallel, AA/BB, and AB/BA designs (Q1634258) (← links)
• Bayesian crossover designs for generalized linear models (Q1658721) (← links)
• On uniformly balanced crossover designs efficient under subject dropout (Q2320752) (← links)
• A review of uniform cross-over designs (Q2475722) (← links)
• Nonparametric approaches to the analysis of crossover studies (Q2503964) (← links)
• Group sequential crossover trial designs with strong control of the familywise error rate (Q4689943) (← links)
• Notes on power comparison between the sequential parallel comparison and other commonly-used designs (Q5082930) (← links)
• Notes on the two-stage procedure under an incomplete block two-period crossover design (Q5087511) (← links)
• Notes on misspecifying the random effects distribution regarding analysis under the AB/BA crossover trial in dichotomous data – a Monte Carlo evaluation (Q5087945) (← links)
• On wide sense stationary processes over finite non-abelian groups (Q5193407) (← links)